Protocol No. 156-08-271: Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Efficacy and Safety of Oral Tolvaptan Tablet Regimens in Subjects with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Project: Research project

StatusFinished
Effective start/end date2/16/112/16/17

Funding

  • Covance Inc. (Protocol No. 156-08-271)
  • Otsuka Pharmaceutical Development & Commercialization, Inc. (Protocol No. 156-08-271)